Untitled - The Canadian Association of Gastroenterology

742 PRINCIPES FONDAMENTAUX DE GASTRO-ENTÉROLOGIE
Larrey D, Pageaux GP. Hepatotoxicity of herbal remedies and mushrooms. Sem Liver
Dis 1995; 15:183-188.
Minuk GY. Canadian Association of Gastroenterology practice guidelines: evaluation
of abnormal liver enzyme tests. Can J Gastroenterol 1998; 12:417-421.
Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic
patients. N Eng J Med 2000; 342:1266-1271.
Villeneuve JP. Les hépatites virales. Bulletin de l’Association des Gastroentérologues
du Québec, août 1998. www.agec.qc.ca.
Section 4 Le foie et l’élimination des médicaments
Michaud V, Turgeon J. Les cytochromes P450 et leur rôle clinique. Le Médecin du
Québec 2002; 37:73-84.
Sherlock S, Dooley J. Drugs and the liver. In: Sherlock S, Pooley J (eds.). Diseases of
the liver and biliary system. 13th ed. Oxford: Blackwell Science, 2002:335-364.
Villeneuve JP, Pichette V. Cytochrome 450 and liver disease. Curr Drug Metab 2004;
5:273-282.
Watkins PB. Mechanisms of drug-induced liver injury. In: Schiff ER, Sorrell MF,
Maddrey WC (eds.). Schiff’s diseases of the liver. 9th ed. Philadelphia: Lippincott
Williams & Wilkins, 2002:1129-1145.
Wilkinson GR. Pharmacokinetics: The dynamics of drug absorption, distribution, and
elimination. In: Hardman JG, Limberd LE, Gilman AG (eds.). Goodman and
Gilman’s The pharmacological basis of therapeutics. 10th ed. New York: McGraw-
Hill, 2001:3-29.
Section 5 Hyperbilirubinémies congénitales
Okolicsanyi L, Cavestro GM, Guatti-Zuliani C. Hyperbilirubinemia: does it matter?
Can J Gastroenterol 1999; 13:663-668.
Sherlock S, Dooley J. Jaundice. In: Sherlock S, Dooley J (eds.). Diseases of the liver
and biliary system. 13th ed. Oxford: Blackwell Science, 2002:205-218.
Section 6 Hépatite virale aiguë
Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. New
Engl J Med 2004; 350(5):476-481.
Ganem D, Prince AM. Hepatitis B virus infection — natural history and clinical
consequences. New Engl J Med 2004; 350(11):1118-1129.
Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: high rate of both spontaneous
and treatment-induced viral clearance. Gastroenterology 2003; 125:80-88.
Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon
alfa-2b. N Engl J Med 2001; 345:1452-1457.
Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis 2004;
24(Suppl. 1):3-10.
Management of Viral Hepatitis: A Canadian Consensus Conference 2003/2004.
Online at www.hepatology.ca.
Shouval D. Hepatitis B vaccines. J Hepatol 2003; 39(Suppl. 1):S70-76.
Section 7 Hépatite chronique
Davis GL, Wong JB, McHutchison J, et al. Early virologic response to treatment with
peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology
2003; 38:645-652.